SGI
FLGT icon

Summit Global Investments’s Fulgent Genetics FLGT Stock Holding History

Summit Global Investments’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,900
Closed -$368K – 485
2022
Q1 		$368K Buy
+5,900
New +$388K 0.03% 382
2021
Q4 		– Sell
-3,000
Closed -$270K – 567
2021
Q3 		$270K Sell
3,000
-4,300
-59% -$391K 0.02% 406
2021
Q2 		$673K Buy
+7,300
New +$583K 0.04% 290

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Summit Global Investments's FLGT Position: Q2 2022 in Review

Summit Global Investments sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 5,900 shares — an estimated $368K sold.

Summit Global Investments first reported a position in FLGT in Q2 2021 and held it in 3 quarters. The position peaked at $673K in Q2 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Summit Global Investments reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Summit Global Investments sold 5,900 Fulgent Genetics shares in Q2 2022, an estimated $368K.
  • Summit Global Investments first reported a position in Fulgent Genetics in Q2 2021 and held it in 3 quarters.
  • Summit Global Investments's Fulgent Genetics position peaked at $673K in Q2 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Summit Global Investments's 13F filing for Q2 2022, filed 23 Aug 2022.